Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Sanofi Revamps R&D

by Michael McCoy
July 6, 2009 | A version of this story appeared in Volume 87, Issue 27

Pharmaceutical giant Sanofi-Aventis is rearranging its R&D infrastructure, particularly in its home country of France. Research head Marc Cluzel says the company wants to take a more entrepreneurial approach to research and increase its use of outside partners. Although the moves won’t involve outright layoffs, Sanofi says, about 300 people will be affected when sites in Bagneux, Rueil-Malmaison, and Evry, France, are closed and operations move to Chilly-Mazarin. Sanofi says it may divest its Porcheville site, where about 200 people are employed. And some sites in the U.S., U.K., Spain, and Japan will be sold or repurposed.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.